Dr. Convit, two days after graduating from medical school, moves to the leprosarium of Cabo Blanco to care and find a cure for leprosy patients. A long journey begins in the fight against Leprosy.

Thanks to Dr. Convit and his team, Venezuela becomes the first country to close the leprosariums and treat patients.

The first assays for an experimental immunotherapy against Leprosy take place.

An effective specific immunotherapy (vaccine) to treat Leprosy is finally developed.

Dr. Convit successfully develops an immunotherapy (vaccine) against Cutaneous Leishmaniasis.

A proposal of a breast cancer immunotherapy (vaccine) is published in Venezuela’s national scientific journal, Gaceta Médica de Caracas.

A pilot study using Dr. Convit's cancer vaccine in patients with advanced breast cancer is performed.

Dr. Jacinto Convit passes away (1913-2014).

The results of the pilot study are published in a peer-reviewed journal Clinical & Translational Oncology. A new pre-clinical study starts.

JCWO begins its international efforts to promote and preserve Dr. Convit’s legacy and support the programs performed by its sister organization, Fundación Jacinto Convit.

The results of the pre-clinical study using Dr. Convit's cancer vaccine are published in a peer-reviewed journal Oncotarget.